Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: FOSUN PHARMA(600196) the Revenue is 10.37 B (+3.63%), Miss estimate;the EBIT is 1.241 B (+30.85%), Beat estimate;the EPS is 0.32 (-8.57%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
10.37B3.63%
10.66B6.50%
-0.29B2.87%
EBITExceed expectations
1.24B30.85%
0.96B1.14%
+0.28B29.71%
EPSMiss expectations
0.328.57%
0.3551.43%
-0.035010.00%
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf